von Willebrand factor antigen and fibronectin in essential hypertension

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results.

European journal of cancer (Oxford, England : 1990)·2018

Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1.

Leukemia·2016

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group.

Leukemia research·2015

Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia.

Leukemia research·2015

The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features.

Annals of hematology·2014

BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.

Annals of hematology·2013

Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management.

Thrombosis research·2026

Comparative validation of AHA/ACC 2026 and ESC 2019 risk stratification in hospitalized patients with acute pulmonary embolism.

Thrombosis research·2026

Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study.

Thrombosis research·2026

Tranexamic acid and its use in early pregnancy; a scoping review.

Thrombosis research·2026

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Thrombosis research·2026

Plasma kallikrein in breast cancer cells: Interactions with urokinase plasminogen activator system and syndecans.

Thrombosis research·2026

Successful treatment of refractory hemophagocytic lymphohistiocytosis complicating Epstein-Barr virus-positive classic Hodgkin lymphoma with rituximab.

Journal of clinical and experimental hematopathology : JCEH·2026

[Complement-coagulation crosstalk in immunothrombosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Hematological diseases caused by excessive complement activation].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Utility of global coagulation assays for hemostasis management in hyperclearance-type autoimmune acquired coagulation factor V deficiency].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Association of Pretreatment Hepatic Function Markers with Clazosentan-Associated Fluid Retention in Patients with Subarachnoid Hemorrhage.

Biological & pharmaceutical bulletin·2026

Related Experiment Videos

von Willebrand factor antigen and fibronectin in essential hypertension

Related Concept Videos

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results.

Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1.

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group.

Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia.

The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features.

BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.

Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management.

Comparative validation of AHA/ACC 2026 and ESC 2019 risk stratification in hospitalized patients with acute pulmonary embolism.

Direct oral anticoagulants versus vitamin K antagonists after venous thrombosis in antiphospholipid syndrome: Recurrence, safety, and exploratory phenotype analysis. A real-life cohort study.

Tranexamic acid and its use in early pregnancy; a scoping review.

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Plasma kallikrein in breast cancer cells: Interactions with urokinase plasminogen activator system and syndecans.

Successful treatment of refractory hemophagocytic lymphohistiocytosis complicating Epstein-Barr virus-positive classic Hodgkin lymphoma with rituximab.

[Complement-coagulation crosstalk in immunothrombosis].

[Hematological diseases caused by excessive complement activation].

[Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm].

[Utility of global coagulation assays for hemostasis management in hyperclearance-type autoimmune acquired coagulation factor V deficiency].

Association of Pretreatment Hepatic Function Markers with Clazosentan-Associated Fluid Retention in Patients with Subarachnoid Hemorrhage.

Related Experiment Videos

von Willebrand factor antigen and fibronectin in essential hypertension

Related Concept Videos

Related Articles